Pacific Biosciences of California PACB Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total Revenue by Product | |||||
| Consumable revenue | $81.94M+16.4% | $70.37M+11.0% | $63.42M+5.7% | $59.98M+14.9% | |
| Instrument revenue | $53.82M-18.2% | $65.78M-45.4% | $120.45M+147% | $48.72M-20.6% | |
| Total Revenue by Geography | |||||
| Americas | $72.8M-7.5% | $78.71M-25.7% | $105.94M+52.3% | $69.56M— | |
| Asia-Pacific | $43.16M+6.0% | $40.71M-25.2% | $54.45M+50.7% | $36.15M+1.2% | |
| Europe, Middle East and Africa | $44.05M+27.3% | $34.59M-14.9% | $40.66M+79.9% | $22.6M— | |
| United States | $69.7M-7.4% | $75.3M-25.1% | $100.5M+50.4% | $66.8M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Pacific Biosciences of California break its business down?
- Pacific Biosciences of California (PACB) reports total revenue by product across 3 parts — Consumable revenue, Instrument revenue and Service and other revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Pacific Biosciences of California's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Pacific Biosciences of California's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
